JPS59204185A - Novel manufacture of alpha-hydroxy-2-thiophene acetic acid derivative - Google Patents

Novel manufacture of alpha-hydroxy-2-thiophene acetic acid derivative

Info

Publication number
JPS59204185A
JPS59204185A JP58136930A JP13693083A JPS59204185A JP S59204185 A JPS59204185 A JP S59204185A JP 58136930 A JP58136930 A JP 58136930A JP 13693083 A JP13693083 A JP 13693083A JP S59204185 A JPS59204185 A JP S59204185A
Authority
JP
Japan
Prior art keywords
compound
formula
hydroxy
methyl
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58136930A
Other languages
Japanese (ja)
Other versions
JPH0439469B2 (en
Inventor
ジヤツク・プロスト・マレシヤル
ジヨルジユ・トマシク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS59204185A publication Critical patent/JPS59204185A/en
Publication of JPH0439469B2 publication Critical patent/JPH0439469B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 (ここで、Rは1〜4個の炭素原子を持つアルキル基を
表わし、R1、R2及びR3  のそれぞれは同一又は
異なっていてよく、水素原子又は1〜4個の炭素原子を
持つアルキル基を表わす)のα−ヒドロキシ−2−チオ
7工ン酢酸銹導体の製造法を主題とする。
Detailed Description of the Invention (Here, R represents an alkyl group having 1 to 4 carbon atoms, each of R1, R2, and R3 may be the same or different, and each of R1, R2, and R3 may be the same or different, and The subject matter is a method for producing an α-hydroxy-2-thio-7-acetic acid salt conductor (representing an alkyl group having a carbon atom).

これらの化合物は、製薬用化合物、特に抗炎症性化合物
の製造に有用な中間体化合物である。
These compounds are useful intermediate compounds in the production of pharmaceutical compounds, especially anti-inflammatory compounds.

式(I)の化合物から出発し、そしてF.Clemen
ce氏他によりEur.J, Med− Chem, 
 1 9 7 4 ( 9 )、690に又は仏国特許
第2, 1 6 7, 35 4号に記載の方法により
次式(A) の化合物を製造することができる。この方法は、温和な
余端還元剤、例えば塩酸中の塩化第一すずを用いること
を特徴とする。
Starting from a compound of formula (I) and F. Clemen
Eur. ce et al. J, Med-Chem,
The compound of the following formula (A) can be prepared by the method described in FR 2,167,354 or in French Patent No. 2,167,354. This method is characterized by the use of a mild residual reducing agent, for example stannous chloride in hydrochloric acid.

式(A)のこれらの化合物は、薬理学的性質を持つ目的
化合物に変撲することができる。このような変換は、例
えば、既に示した仏国特許第2、 0 6 8, 4 
2 5号及び同2, 1 6 7, 3 3 4号に記
載されている。
These compounds of formula (A) can be modified into target compounds with pharmacological properties. Such a conversion is described, for example, in the already indicated French Patent No. 2, 0 6 8, 4
25 and 2, 167, and 334.

先に示した文献のFJur.J, Med, Chem
, 1 9 7 4( 9 ) 、 T)、390には
、式(I)の化合物の製造法が記載されている。この方
法は下記の通りである。
FJur. J, Med, Chem
, 1974(9), T), 390 describes a method for preparing compounds of formula (I). This method is as follows.

ここに、2−ハロケオフエンと次式 の酸から出発して式(I)の誘導体の新製進法が開発さ
れた。
A new process for the preparation of derivatives of formula (I) has now been developed starting from 2-halokeophene and an acid of formula (I).

これらの二つの化合物は容易に入手でき、また反応は中
間体化合物を単離することなく行うことができる。
These two compounds are readily available and the reaction can be carried out without isolating the intermediate compound.

本発明の目的をなすこの方法は、次式(II)(ここで
Xはハロゲン原子を表わす) の化合物に次式(III) す (ここでRは既に示した意味を有し、Aは水素原子、ア
ル〃り金属原子又は当量のマグネシウム若しくはアルカ
リ土金属原子を表わす) の化合物を作用させ、マグネシウム基を加水分解した後
、所期の式(I)の化合物を得ることを特徴とする。
This process, which forms the object of the present invention, comprises converting a compound of the following formula (II), in which X represents a halogen atom, into a compound of the following formula (III), in which R has the meaning already indicated and A is hydrogen. (representing an atom, an alkali metal atom, or an equivalent amount of a magnesium or alkaline earth metal atom) to hydrolyze the magnesium group, thereby obtaining the desired compound of formula (I).

置換基1’(、R4、R2及びR3が表わずことのでき
る意味としては、低級アルキル基、即ちメチル、エチル
、プロピル、イソプロピル、ブチル、イソブチル、5e
c−ブチル又はt−ブチルがあげられる。Xは塩素、よ
う素又は臭素原子を表わすことができる。臭素原子が好
ましい。
Substituent 1' (, R4, R2 and R3 may have lower alkyl groups, i.e. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, 5e
Examples include c-butyl and t-butyl. X can represent a chlorine, iodine or bromine atom. A bromine atom is preferred.

Aは、水素の他に、ナトリウム、カリウム又はリチウム
原子を表わすことができる。水素又はリチウムが好まし
く、特にリチウムが好ましい。また、Aは当量のマグネ
シウム又はカルシウム若しくはスーリウムのようなアル
カリ土金属原子を表わすこともできる。
In addition to hydrogen, A can represent a sodium, potassium or lithium atom. Hydrogen or lithium is preferred, particularly lithium. A can also represent an equivalent amount of an alkaline earth metal atom such as magnesium or calcium or thurium.

式(m)の化合物に作用させる式(II)のマグネシウ
ム化合物は、好ましくは、テトラヒドロフラン又はエチ
ルエーテルのような有機溶媒中で必要時に即座に製造さ
れる。
The magnesium compound of formula (II) acting on the compound of formula (m) is preferably prepared extemporaneously on demand in an organic solvent such as tetrahydrofuran or ethyl ether.

アルカリ金属塩、好ましくはリチウム塩が式(III)
の化合物として用いられるときは、この塩は、トルエン
又はテトラヒドロフランのような有機溶媒中で必要時に
即座に製造することもできる。ベンゼン又はエチルエー
テルのようなエーテルも用いることができる。
An alkali metal salt, preferably a lithium salt, of formula (III)
When used as a compound, the salt can also be prepared extemporaneously in an organic solvent such as toluene or tetrahydrofuran. Ethers such as benzene or ethyl ether can also be used.

反応は、マグネシウムの製造が行われた上記のような溶
媒又は溶媒混合物中で行われる。
The reaction is carried out in a solvent or solvent mixture such as those mentioned above in which the magnesium preparation was carried out.

マグネシウム化合物の加水分解は、水性酸媒体中で行わ
れ、そして用いられる酸は塩酸、硫酸又は酢酸である。
Hydrolysis of the magnesium compound is carried out in an aqueous acid medium and the acids used are hydrochloric acid, sulfuric acid or acetic acid.

操作は、塩化アンモニウムの存在下に行うこともできる
The operation can also be carried out in the presence of ammonium chloride.

特に、本発明は、ノ翫ロゲン化2−チェニルマグネシウ
ムより出発して方法を上記のように実施することを特徴
とする次式(T’) (ここでRは前記の意味を有する) の化合物の製造法を主題とする。
In particular, the invention is characterized in that the process is carried out as described above starting from halogenated 2-chenylmagnesium of the following formula (T'), where R has the meaning given above: The subject is methods for producing compounds.

さらに詳しくは、本発明は、Rがメチル又はエチル基を
表わす式(1■)の化合物を上記の方法に用いることを
特徴とするRがメチル又はエチル基を表わす式(T’)
の化合物の製造法を主題とする。
More specifically, the present invention is characterized in that a compound of formula (1) in which R represents a methyl or ethyl group is used in the above method.
The subject matter is a method for producing compounds of

さらに、本発明の主題をなす方法は、前記の方法に、R
1、R2及びR3のそれぞれが水素原子を表−1っず式
(JT)の化合物とRがメチル基を表わす式(liI)
の化合物を用いることを特徴とするα−メチル−α−ヒ
ドロキシ−2−チオフェン酢酸の製造に係る。
Furthermore, the method that is the subject of the invention further comprises the addition of R to the aforementioned method.
1. Compounds of formula (JT) in which each of R2 and R3 is a hydrogen atom and formula (liI) in which R represents a methyl group
The present invention relates to the production of α-methyl-α-hydroxy-2-thiophene acetic acid characterized by using the compound of

好ましくは、Xが臭素原子を表わす式(H)の化合物及
びAが水素又はリチウム原子を表わす式(III、)の
化合物が本発明の主題をなす方法の出発物質として用い
られる。
Preferably, compounds of the formula (H) in which X represents a bromine atom and compounds of the formula (III,) in which A represents a hydrogen or lithium atom are used as starting materials for the process that is the subject of the invention.

得られたマグネシウム化合物の加水分解は、水性酸媒体
中で行われる。
Hydrolysis of the obtained magnesium compound is carried out in an aqueous acid medium.

最後に、本発明の主題は、特に、臭化2−チェニルマグ
ネシウムをピルビン酸リチウムに作用させ、得られた生
成物を塩酸水溶液により加水分解することを特徴とする
α−メチル−α−ヒドロキシ−2−チオフェン酢酸の製
造法に係る。
Finally, the subject of the invention provides, in particular, for the treatment of alpha-methyl-alpha-hydroxy -Relates to a method for producing 2-thiophene acetic acid.

下記の例は本発明を例示するもので、これを何ら制限し
ない。
The examples below are illustrative of the invention and do not limit it in any way.

例1:α−メチルーα−ヒドロキシ−2−チオフェン酢
酸 7、96kgの戻酸リチウムを2101のトルエンに加
えてなる1′1′δ濁液を加熱沸騰させ、内部温度を1
05〜108°Cの間の温度に保ち且つ生成する水をデ
カンテーションしながら攪拌下に2時間で24.6kg
のピルビン酸を導入する。この混合物を1時間半還流さ
せると共に4ノの生成水とピルビン酸との混合物がデカ
ンテーションされた。
Example 1: α-Methyl-α-hydroxy-2-thiophene acetic acid 7. A 1'1'δ suspension obtained by adding 96 kg of rehydrated lithium to 2101 parts of toluene was heated to boiling, and the internal temperature was reduced to 1.
24.6 kg in 2 hours under stirring while maintaining the temperature between 05 and 108°C and decanting the water produced.
of pyruvate is introduced. The mixture was refluxed for 1.5 hours and the mixture of 4 volumes of produced water and pyruvic acid was decanted.

次いで、この混合物を常圧で約30分間蒸留して栄後の
微量の水と酸を除去する。これにより351のトルエン
−酸−水混合物を集めた。
This mixture is then distilled at normal pressure for about 30 minutes to remove trace amounts of water and acid. This collected 351 toluene-acid-water mixtures.

1))臭化マグネシウムチェニルの製造アルゴン雰囲気
下に5.74 kgのマグネシウム片を815ノのテト
ラヒドロフランに導入し、続いて約25gの昇華させた
よう素を入れる。これを2D〜25°Cの間で10分間
かきまぜ、次いで55kpの2−ブロムチオフェンを6
0ノのテトラヒドロフランに溶解してなる溶液の約51
を導入する。開始後温度は65℃に上昇する。安定した
ならば、上で14製した2−ブロムチオフェン溶液の残
りを同じ温度を維持しながら1時間30分にわたり徐々
に導入する。導入が終ったならば、温度を60〜ろ5°
Cに保ちながら混合物をアルゴン雰囲気下に2時間かき
まぜる。
1)) Preparation of Chenyl Magnesium Bromide 5.74 kg of magnesium pieces are introduced into 815 kg of tetrahydrofuran under an argon atmosphere, followed by about 25 g of sublimed iodine. This was stirred for 10 minutes between 2D and 25°C, then 55 kp of 2-bromothiophene was added to 6
About 51% of a solution dissolved in 0% tetrahydrofuran
will be introduced. After starting, the temperature rises to 65°C. Once stabilized, the remainder of the 2-bromothiophene solution prepared above in 14 is gradually introduced over 1 hour and 30 minutes while maintaining the same temperature. Once the introduction is complete, reduce the temperature to 60~5°.
The mixture is stirred under an argon atmosphere for 2 hours while maintaining the temperature at 100°C.

C)縮合 上4e+7)a)で得たピルビン酸リチウムの懸濁液を
かきまぜながら一15℃に冷却し、上記のi))で調製
したマグネシウム溶液を窒素圧力により移動させること
により約5分間で徐々に導入すると同時に懸濁液を−1
5〜−20℃の温度の塩水の外部循環により冷却する。
C) Condensation 4e + 7) The suspension of lithium pyruvate obtained in a) was cooled to -15°C while stirring, and the magnesium solution prepared in i)) was transferred in about 5 minutes by nitrogen pressure. Gradually introduce the suspension at the same time as −1
Cooling is achieved by external circulation of brine at a temperature of 5 to -20°C.

温度は約45℃に上昇する。導入中にマグネシウム溶液
は激しい攪拌により分散される。懸濁液を35/のテト
ラヒドロフランで洗い、次いで約30分間で内部温度を
徐々に20〜25℃に低下させ、混合物をこの温度で窒
素下に約16時間かきまぜる。
The temperature rises to about 45°C. During introduction, the magnesium solution is dispersed by vigorous stirring. The suspension is washed with 35° C. of tetrahydrofuran, the internal temperature is then gradually lowered to 20-25° C. over about 30 minutes, and the mixture is stirred at this temperature under nitrogen for about 16 hours.

この懸濁液を140kgの砕氷と47ノの塩酸との混合
物に約15分間で注ぐ。内部温度を必要なら氷を加えて
25℃に保つ。装置を50I!の水で洗い、pHを塩酸
により1に調節する。溶解し終るまで20〜25℃にか
きまぜた後、有機相を分離し、水性相を6回抽出する(
それぞれ200のトルエン)。有機相を一緒にし、次い
で121!の水を加え、pH4まで約1.51のアンモ
ニアをゆっくりと入れる。デカンテーションし、再び1
21の蒸留水で洗い、次いで少量のアンモニアをpH4
まで加え、有機相を分離し、減圧下で122ノの容積ま
で濃縮させ、内部温度を40℃以下に保って、テトラヒ
ドロ7ラン及び水を含有する約1751のトルエンを集
める。3回の連続蒸留をそれぞれ701のトルエンを用
いて同じ条件で行う。0℃に冷却し、この温度で2時間
かきまぜた後、得られた生成物を分離し、55100℃
のトルエンで2回洗い、オープンで乾燥する。2765
kgの所期生成物を得た。M P = 115℃。
This suspension is poured over a period of about 15 minutes onto a mixture of 140 kg of crushed ice and 47 g of hydrochloric acid. Keep the internal temperature at 25°C by adding ice if necessary. 50I equipment! of water and adjust the pH to 1 with hydrochloric acid. After stirring at 20-25 °C until complete dissolution, the organic phase is separated and the aqueous phase is extracted 6 times (
200 toluene each). Combine the organic phases and then 121! of water and slowly add ammonia of about 1.51 to pH 4. Decant and again
Wash with distilled water at pH 21, then add a small amount of ammonia to pH 4.
The organic phase is separated and concentrated under reduced pressure to a volume of 122° C., keeping the internal temperature below 40° C., to collect about 1751° C. of toluene containing tetrahydrochloride and water. Three consecutive distillations are carried out under the same conditions, each using 701 g of toluene. After cooling to 0°C and stirring at this temperature for 2 hours, the product obtained was separated and heated to 55100°C.
Wash twice with toluene and dry in the open. 2765
kg of expected product was obtained. M P = 115°C.

751の220最塩酸と751(gの塩化第一すずとの
混合物を墾素下に40℃に加熱し、これに1251の氷
酢酸を一度に加える。溶解し終ったならば、501(g
のα−メチル−α−ヒドロキシ−2−チオフェン酢酸を
窒素パージし且つかきまぜ7よがら徐々に導入する。窒
素パージし且つかきまぜながら温度を40℃に保つ。次
いで20〜25℃に冷却し、150〕の脱塩水と1oo
kyの砕氷との混合物に15分間で注入し、再び15分
間かきませた後に、水性相をSOZの20°C±2℃の
ジクロルエタンで6回抽出する。ジクロルエタン抽出物
を8.51の22013e塩酸を42.57の水に入れ
たもので4回、次いで50Aの水で3回洗う。
A mixture of 751 of 220 hydrochloric acid and 751 (g of stannous chloride) is heated to 40°C under chlorine and 1251 of glacial acetic acid is added all at once. Once dissolved, 501 (g of
of .alpha.-methyl-.alpha.-hydroxy-2-thiopheneacetic acid is gradually introduced while purging with nitrogen and stirring. Maintain temperature at 40° C. with nitrogen purge and stirring. Then, cool to 20-25°C and add 150% demineralized water and 100%
After pouring into the mixture with crushed ice for 15 minutes and stirring again for 15 minutes, the aqueous phase is extracted 6 times with dichloroethane at 20° C. ± 2° C. in SOZ. Wash the dichloroethane extract four times with 8.51 parts of 22013e hydrochloric acid in 42.57 parts of water, then three times with 50A of water.

ジクロルエタン溶液を4D℃を越えないようにして減圧
下に濃縮する。約2251のジクロルエタンを集め、そ
して45.3 kgの所期の粗製酸を得た。
The dichloroethane solution is concentrated under reduced pressure without exceeding 4D°C. Approximately 2251 of dichloroethane was collected and 45.3 kg of the desired crude acid was obtained.

この生成物を0,7トールの圧力下に120℃を越えな
いように蒸留する。39.45 kgの所期生成物を得
た。
This product is distilled under a pressure of 0.7 torr and not above 120°C. 39.45 kg of expected product was obtained.

エン酢酸 675gの2−ブロムチオフェンを500ゴのテトラヒ
ドロフランに溶解してなる溶液の50ccを、593g
のマグネシウム片と750eeのテトラヒドロフランと
の混合物に導入する。よう素結晶を加える。反応開始後
、ブロムチオフェン溶液の残部を65℃でかきまぜなが
ら1時間で導入する。導入後2時間かきまぜ続けると共
に温度を25℃に低下させる。
593 g of 50 cc of a solution prepared by dissolving 675 g of 2-bromothiophene in 500 g of tetrahydrofuran
of magnesium pieces and 750 ee of tetrahydrofuran. Add iodine crystals. After the reaction has started, the remainder of the bromothiophene solution is introduced at 65° C. with stirring for 1 hour. Stirring is continued for 2 hours after introduction and the temperature is lowered to 25°C.

次いで、102,9のピルビン酸を500ccのテトラ
ヒドロンランに溶解してなる溶液を25℃で45分間に
わたり加える。この混合物を251℃で18時間かきま
ぜ、次いで130eCの66°Ba塩酸を含有する2、
61の氷水混合物に注加し、10分間かきまぜる。有機
相をデカンテーションし、260ccの酢酸エチルで4
回再抽出する。有機相を260CQの脱塩水で2回洗い
、次いでまず520ω、次いで260cc(3回)の2
N冷水酸化ナトリウムで再抽出する。ナトリウム液を2
60CCの酢(2)エチルで4回洗い、氷の存在下にか
きまぜながら120ccの22°Be塩酸を添加してp
H1まで酸性化する。まず520eC,次いで260C
C(3回)の酢酸エチルで抽出することによって、生じ
た有機相を26DCCの脱塩水で2回洗い、硫酸ナトリ
ウムで乾燥し、約ioyの活性炭を加える。分離した後
、溶媒な波圧下に蒸発させ、145.5.Fの所期生成
物を得た。
A solution of 102,9 pyruvic acid dissolved in 500 cc of tetrahydrone is then added at 25° C. for 45 minutes. The mixture was stirred for 18 hours at 251°C, then 2 containing 66°Ba hydrochloric acid at 130eC.
61 into the ice-water mixture and stir for 10 minutes. The organic phase was decanted and diluted with 260 cc of ethyl acetate.
Re-extract twice. The organic phase was washed twice with 260 CQ of demineralized water, then first with 520 ω and then with 260 cc (3 times) of 2
Re-extract with N cold sodium hydroxide. 2 drops of sodium solution
Wash 4 times with 60cc of vinegar (2) ethyl and add 120cc of 22°Be hydrochloric acid with stirring in the presence of ice to p.
Acidify to H1. First 520eC, then 260C
By extracting with C (3 times) of ethyl acetate, the resulting organic phase is washed twice with 26 DCC of demineralized water, dried over sodium sulphate and about ioy of activated carbon is added. After separation, the solvent is evaporated under wave pressure and 145.5. The expected product of F was obtained.

代理人の氏名  倉 内 基 弘 同      倉  橋     暎Agent's name: Motohiro Kurauchi Same storehouse bridge

Claims (7)

【特許請求の範囲】[Claims] (1)次式(I) 凡 (ここで、Rは1〜4個の炭素原子を持つアルキル基を
表わし、R1、R2及びR3のそれぞれは同−又は異な
っていてよく、水素原子又は1〜4個の炭素原子を持つ
アルキル基を表わす)のα−ヒドロキシ−2−チオフェ
ン酢酸誘導体を製造するにあたり、次式(n) (ここでXはハロゲン原子を表わす) の化合物に次式<m> R−C−CO2A          (UI)(ここ
でRは既に示した意味を有し、Aは水素原子、アルカリ
金属原子又は当量のマグネシウム若しくはアルカリ土金
属原子を表わす) の化合物を作用させ、マグネシウム基を加水分解した後
、所期の式(I)の化合物を得ることを特徴とするα−
ヒドロキシ−2−チオフェン酢酸誘導体の製造法。
(1) The following formula (I) (Here, R represents an alkyl group having 1 to 4 carbon atoms, each of R1, R2 and R3 may be the same or different, and a hydrogen atom or 1 to 4 carbon atoms may be used. In producing an α-hydroxy-2-thiophene acetic acid derivative (representing an alkyl group having 4 carbon atoms), the following formula <m> is added to a compound of the following formula (n) (where X represents a halogen atom). A compound of R-C-CO2A (UI) (where R has the meaning already indicated and A represents a hydrogen atom, an alkali metal atom, or an equivalent magnesium or alkaline earth metal atom) is reacted to form a magnesium group. α- characterized in that after hydrolysis, the desired compound of formula (I) is obtained.
A method for producing a hydroxy-2-thiophene acetic acid derivative.
(2)  ハロゲン化2−チェニルマグネシウムヨリ出
発して特許請求の範囲第1項記載の方法を実施して次式
((I) (ここでRは特許請求の範囲第1項で既に示した意味を
有する) の化合物を得ることを特徴とする特許請求の範囲第1項
記載の方法。
(2) Starting from halogenated 2-chenylmagnesium and carrying out the method described in claim 1, the following formula ((I) (where R is the same as already shown in claim 1) 2. A method according to claim 1, characterized in that a compound having the meaning ) is obtained.
(3)Rがメチル又はエチル基を表わす式(m)の化合
物を特許請求の範囲第1項記載の方法で用いてRがメチ
ル又はエチル基を表わす特許請求の範囲第2項記載の式
(I’)の化合物を得ることを特徴とする特許請求の範
囲第1又は2項記載の方法。
(3) A compound of formula (m) in which R represents a methyl or ethyl group is used in the method described in claim 1, and the compound of the formula (m) in which R represents a methyl or ethyl group is 3. A method according to claim 1 or 2, characterized in that the compound of I') is obtained.
(4) R1、R2及びR3がそれぞれ水素原子を衰わ
す式(IF)の化合物とRがメチル基を表わす式(II
I)の化合物を特許請求の範囲第1項記載の方法で用い
てα−メチル−α−ヒドロキシ−2−チオフェン酢酸を
得ることを特徴とする特許請求の範囲第1〜3項のいず
れかに記載の方法。
(4) A compound of formula (IF) in which R1, R2 and R3 each represent a hydrogen atom, and a compound of formula (II) in which R represents a methyl group.
According to any one of claims 1 to 3, wherein the compound I) is used in the method described in claim 1 to obtain α-methyl-α-hydroxy-2-thiophene acetic acid. Method described.
(5)Xが臭素原子を表わす式(II)の化合物とAが
水素又はリチウム原子を表わす式(III)の化合物よ
り出発して特許請求の範囲第1項記載の方法を実施する
ことを特徴とする特許請求の範囲第1〜4項のいずれか
に記載の方法。
(5) The method according to claim 1 is carried out starting from a compound of formula (II) in which X represents a bromine atom and a compound of formula (III) in which A represents a hydrogen or lithium atom. A method according to any one of claims 1 to 4.
(6)  マグネシウム基の加水分解を水性酸媒体中で
行うことを特徴とする特許請求の範囲第1〜5項のいず
れかに記載の方法。
(6) The method according to any one of claims 1 to 5, characterized in that the hydrolysis of the magnesium group is carried out in an aqueous acid medium.
(7)  ピルビン酸リチウムに臭化2−チェニルマグ
ネシウムを作用させ、得られた生成物を塩酸水溶液によ
り加水分解してα−メチル−α−ヒドロキシ−2−チオ
フェン酢酸を得ることを特徴とする特許請求の範囲第1
〜6項のいずれかに記載の方法。
(7) A method characterized by reacting lithium pyruvate with 2-chenylmagnesium bromide and hydrolyzing the resulting product with an aqueous hydrochloric acid solution to obtain α-methyl-α-hydroxy-2-thiopheneacetic acid. Claim 1
6. The method according to any one of items 6 to 6.
JP58136930A 1983-04-28 1983-07-28 Novel manufacture of alpha-hydroxy-2-thiophene acetic acid derivative Granted JPS59204185A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8307021A FR2545085B1 (en) 1983-04-28 1983-04-28 NOVEL PROCESS FOR THE PREPARATION OF A-HYDROXY 2-THIOPHENE ACETIC ACID DERIVATIVES
FR8307021 1983-04-28

Publications (2)

Publication Number Publication Date
JPS59204185A true JPS59204185A (en) 1984-11-19
JPH0439469B2 JPH0439469B2 (en) 1992-06-29

Family

ID=9288331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58136930A Granted JPS59204185A (en) 1983-04-28 1983-07-28 Novel manufacture of alpha-hydroxy-2-thiophene acetic acid derivative

Country Status (22)

Country Link
JP (1) JPS59204185A (en)
KR (1) KR900006558B1 (en)
AT (1) AT392786B (en)
AU (1) AU559749B2 (en)
BE (1) BE897362A (en)
CA (1) CA1201443A (en)
CH (1) CH655316A5 (en)
DE (1) DE3325456A1 (en)
DK (1) DK157493C (en)
ES (1) ES524648A0 (en)
FI (1) FI832473L (en)
FR (1) FR2545085B1 (en)
GB (1) GB2139215B (en)
HU (1) HU194206B (en)
IE (1) IE55905B1 (en)
IT (1) IT1171855B (en)
LU (1) LU84931A1 (en)
NL (1) NL8302564A (en)
NZ (1) NZ205514A (en)
PT (1) PT77010B (en)
SE (1) SE451018B (en)
ZA (1) ZA835613B (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1067828A (en) * 1951-01-19 1954-06-18 Sterling Drug Inc Improvements relating to a process for preparing organic chemicals
GB806710A (en) * 1955-07-05 1958-12-31 Metal & Thermit Corp Reactions of organomagnesium chloride complexes
GB820083A (en) * 1955-07-05 1959-09-16 Metal & Thermit Corp Reactions of organomagnesium chloride reagents
FR2068425B1 (en) * 1969-11-12 1973-01-12 Roussel Uclaf
FR2167334A1 (en) * 1972-01-13 1973-08-24 Roussel Uclaf 4-aroyl-5-alkylthiophene-2-acetic acids - with analgesic and antiinflammatory activity
GB1584120A (en) * 1977-07-21 1981-02-04 Sagami Chem Res Process for the preparation of thiophene derivatives and thiophene derivatives obtained therethrough
GB2030131B (en) * 1978-09-12 1982-12-22 Taiyo Pharma Ind Process for producing 2-(4-(2-thienyl-carbonyl) phenyl) propionic acid
JPS5835145A (en) * 1981-08-26 1983-03-01 Taisho Pharmaceut Co Ltd Preparation of alpha-arylalkanoic acid ester

Also Published As

Publication number Publication date
ES8404345A1 (en) 1984-05-01
AT392786B (en) 1991-06-10
IT1171855B (en) 1987-06-10
KR840008351A (en) 1984-12-14
DK157493C (en) 1990-06-11
DK307583D0 (en) 1983-07-04
NZ205514A (en) 1987-03-31
KR900006558B1 (en) 1990-09-13
PT77010A (en) 1983-08-01
SE8303887D0 (en) 1983-07-07
NL8302564A (en) 1984-11-16
ES524648A0 (en) 1984-05-01
JPH0439469B2 (en) 1992-06-29
IE832074L (en) 1984-10-28
ATA286883A (en) 1990-11-15
FI832473L (en) 1984-10-29
IE55905B1 (en) 1991-02-14
HU194206B (en) 1988-01-28
PT77010B (en) 1986-04-11
GB2139215A (en) 1984-11-07
DK307583A (en) 1984-10-29
AU559749B2 (en) 1987-03-19
FR2545085A1 (en) 1984-11-02
CA1201443A (en) 1986-03-04
DE3325456C2 (en) 1993-04-29
SE451018B (en) 1987-08-24
BE897362A (en) 1984-01-25
GB8323492D0 (en) 1983-10-05
IT8348823A0 (en) 1983-08-08
ZA835613B (en) 1985-03-27
FI832473A0 (en) 1983-07-05
DK157493B (en) 1990-01-15
AU1730983A (en) 1984-11-01
GB2139215B (en) 1986-10-08
SE8303887L (en) 1984-10-29
DE3325456A1 (en) 1984-10-31
LU84931A1 (en) 1984-03-22
FR2545085B1 (en) 1985-10-25
CH655316A5 (en) 1986-04-15

Similar Documents

Publication Publication Date Title
KR900003279B1 (en) Process for preparing l-ascorbic acid
US4284797A (en) Process for separating mixtures of 3- and 4-nitrophthalic acid
JPS59204185A (en) Novel manufacture of alpha-hydroxy-2-thiophene acetic acid derivative
JPS6034954B2 (en) Method for producing 3,4-methylenedioxymandelic acid
JPS60226879A (en) Manufacture of n1-methyl-10 alpha-methoxylumilysergol
GRUNDMANN et al. Triazines. XVII. s-Triazine from s-Triazine-2, 4, 6-tricarbonic Acid
JPS6157302B2 (en)
JPH0531556B2 (en)
JPH04503218A (en) Improved process for producing intermediates for the production of bambuterol
JPS6351156B2 (en)
JPH07206816A (en) Preparation of 2,4,5-tribromopyrrole-3-carbonitrile
US4052402A (en) Process for synthesizing codeinone from thebaine
JPS6075471A (en) Preparation of 3,4-diphenylisoxazol-5-acetic acid
JP4221770B2 (en) Process for producing isoquinoline lysate compound
JPS603383B2 (en) Method for producing 6-chloro-α-methyl-carbazole-2-acetic acid
JPH026481A (en) Production of 4-hydroxycoumarin
US6008413A (en) Process for recrystallizing 1,3-bis(aminophenoxy benzene)
JPS61178947A (en) Manufacture of arylalkyl ketone
USRE23406E (en) Nitro
JPS5973566A (en) Manufacture of 3-carboxy-1-methylpyrrol-2- acetic acid
US631761A (en) Process of preparing alkyl-uric acid.
JPH0211572A (en) Purification of hydroxyquinolinecarboxylic acid
JP2000198779A (en) Purification of 3-alkylflavanol derivative
JPS607988B2 (en) Improved synthesis method of 3-amino-5-tert-butyl isoxazole
WO2003048161A1 (en) A process for preparing 2,6-dichloropurine